EGFR and neoplasm: Hoffmann et al. demonstrated that an anti-EGFR monoclonal antibody induced leukocyte infiltration into EGFR-overexpressing tumor spheroids due to an upregulation of chemokine expression mediated by anti-EGFR signal transduction.